Email: contacts@biophics.org
Call Us: +66(2) 354 9181- 6
fbicon 2
lineicon
Menu

Publications

Our publications

  1. Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn, et al. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial. [MEDLINE] 
  2. Anh Duc Dang, Thiem Dinh Vu, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thi Ngoc Dang, Be Van Le, Thai Huu Duong, Duoc Van Nguyen, Saranath Lawpoolsri, Pailinrut Chinwangso, et al. Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam. [MEDLINE] 
  1. Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth J.E. Bines, J. At Thobari, C.D. Satria, A. Handley, E. Watts, D. Cowley, H. Nirwati, J. Ackland, J. Standish, F. Justice, G. Byars, K.J. Lee, G.L. Barnes, N.S. Bachtiar, A. Viska Icanervilia, K. Boniface, N. Bogdanovic‑Sakran, D. Pavlic, R.F. Bishop, C.D. Kirkwood, J.P. Buttery, and Y. Soenarto [MEDLINE]
  2. Kaewkungwal J, Pitisuttithum P, Rerks-Ngarm S, Nitayaphan S, Khamboonruang C, Kunasol P, et al. Issues in women’s participation in a phase III community HIV vaccine trial in Thailand. AIDS Res Hum Retroviruses. 2013; 29(11):1524-34. [MEDLINE] PMCID: 3809940. PMID: 23343395. doi: 10.1089/AID.2012.0265.
  3. Robb ML, Rerks-Ngarm S, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Kunasol P, et al. Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144. Lancet Infect Dis. 2012; 12(7):531-7. [MEDLINE] PMCID: 3530398. PMID: 22652344. doi: 10.1016/S1473-3099(12)70088-9.
  4. Montefiori DC, Karnasuta C, Huang Y, Ahmed H, Gilbert P, de Souza MS, et al. Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials. J Infect Dis. 2012; 206(3):431-41. [MEDLINE] PMCID: 3392187. PMID: 22634875. doi: 10.1093/infdis/jis367.
  5. Karasavvas N, Billings E, Rao M, Williams C, Zolla-Pazner S, Bailer RT, et al. The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120. AIDS Res Hum Retroviruses. 2012; 28(11):1444-57. [MEDLINE] PMCID: 3484815. PMID: 23035746. doi: 10.1089/aid.2012.0103.
  6. Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med. 2012; 366(14):1275-86. [MEDLINE] PMCID: 3371689. PMID: 22475592. doi: 10.1056/NEJMoa1113425.
  7. de Souza MS, Ratto-Kim S, Chuenarom W, Schuetz A, Chantakulkij S, Nuntapinit B, et al. The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope. J Immunol. 2012; 188(10):5166-76. [MEDLINE] PMCID: 3383859. PMID: 22529301. doi: 10.4049/jimmunol.1102756.
  8. Bonsignori M, Pollara J, Moody MA, Alpert MD, Chen X, Hwang KK, et al. Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family. J Virol. 2012; 86(21):11521-32. [MEDLINE] PMCID: 3486290. PMID: 22896626. doi: 10.1128/JVI.01023-12.
  9. Rerks-Ngarm S, Premsri N, Namwat C, Khamboonruang C, Kunasol P, Pitisuttithum P, et al. Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148). Vaccine. 2011; 29(25):4285-92. [MEDLINE] PMID: 21435408. doi: 10.1016/j.vaccine.2011.03.014.
  10. Pitisuttithum P, Rerks-Ngarm S, Bussaratid V, Dhitavat J, Maekanantawat W, Pungpak S, et al. Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand. PLoS One. 2011; 6(12):e27837. [MEDLINE] PMCID: 3244387. PMID: 22205930. doi: 10.1371/journal.pone.0027837.
  11. Suntharasamai P, Martin M, Vanichseni S, Van Griensven F, Mock PA, Pitisuttithum P, et al. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999–2003. Addiction. 2009; 104(2):235-42. [MEDLINE] doi: 10.1111/j.1360-0443.2008.02436.x.
  12. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009; 361(23):2209-20. [MEDLINE] PMID: 19843557. doi: 10.1056/NEJMoa0908492.
  13. Pitisuttithum P, Rerks-Ngarm S, Kaewkungwal J, Nitayaphan S, Khamboonruang C, Kunasol P, et al. P14-05. Recruitment, retention and participation impact events among women participating in phase III community trial in Thailand. Retrovirology. 2009; 6(Suppl 3):P193. [MEDLINE] oi:10.1186/1742-4690-6-S3-P193.
  14. Kim J, Kamasuta C, Trichavaroj R, Kaewkungwal J, Chantakulkij S, Ratto-Kim S, et al. OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV(R) + AIDSVAX(R) B/E prime-boost vaccination in the Thai Phase III Trial. Retrovirology. 2009; 6(Suppl 3):O30. [MEDLINE] doi:10.1186/1742-4690-6-S3-O30.
  15. Vanichseni S, Tappero JW, Pitisuttithum P, Kitayaporn D, Mastro TD, Vimutisunthorn E, et al. Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand. AIDS. 2004; 18(2):311-6. [MEDLINE] PMID: 15075550.
  16. van Griensvan F, Keawkungwal J, Tappero JW, Sangkum U, Pitisuttithum P, Vanichseni S, et al. Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand. AIDS. 2004; 18(2):295-301. [MEDLINE] PMID: 15075548.
  17. Pitisuttithum P, Berman PW, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai LO, et al. Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1. J Acquir Immune Defic Syndr. 2004; 37(1):1160-5. [MEDLINE] PMID: 15319676.
  18. Migasena S, Suntharasamai P, Pitisuttithum P, Kitayaporn D, Wasi C, Huang W, et al. AIDSVAX (MN) in Bangkok injecting drug users: a report on safety and immunogenicity, including macrophage-tropic virus neutralization. AIDS Res Hum Retroviruses. 2000; 16(7):655-63. [MEDLINE] PMID: 10791876. DOI: 10.1089/088922200308882.
  1. Satimai W, Sudathip P, Vijaykadga S, Khamsiriwatchara A, Sawang S, Potithavoranan T, et al. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia. Malar J. 2012; 11:300. [MEDLINE] PMCID: 3445821. PMID: 22929621. doi: 10.1186/1475-2875-11-300.
  2. Khamsiriwatchara A, Sudathip P, Sawang S, Vijakadge S, Potithavoranan T, Sangvichean A, et al. Artemisinin resistance containment project in Thailand. (I): Implementation of electronic-based malaria information system for early case detection and individual case management in provinces along the Thai-Cambodian border. Malar J. 2012; 11:247. [MEDLINE] PMCID: 3464131. PMID: 22839508. doi: 10.1186/1475-2875-11-247.
  3. Wangroongsarb P, Satimai W, Khamsiriwatchara A, Thwing J, Eliades JM, Kaewkungwal J, et al. Respondent-driven sampling on the Thailand-Cambodia border. II. Knowledge, perception, practice and treatment-seeking behaviour of migrants in malaria endemic zones. Malar J. 2011; 10:117. [MEDLINE] PMCID: 3116495. PMID: 21554711. doi: 10.1186/1475-2875-10-117.
  4. Khamsiriwatchara A, Wangroongsarb P, Thwing J, Eliades J, Satimai W, Delacollette C, et al. Respondent-driven sampling on the Thailand-Cambodia border. I. Can malaria cases be contained in mobile migrant workers? Malar J. 2011; 10:120. [MEDLINE] PMCID: 3116496. PMID: 21554744. doi: 10.1186/1475-2875-10-120.
  5. Meankaew P, Kaewkungwal J, Khamsiriwatchara A, Khunthong P, Singhasivanon P, Satimai W. Application of mobile-technology for disease and treatment monitoring of malaria in the “Better Border Healthcare Programme”. Malar J. 2010; 9:237. [MEDLINE] PMCID: 2936405. PMID: 20723223. doi: 10.1186/1475-2875-9-237.
  6. Anuraj M. Malaria Surveillance Using Mobile Phone Technology. 2010; Archived at: https://malariacontainment.wordpress.com/2010/09/28/malaria-surveillance-using-mobile-phone-technology/.
  7. Kongpatanakul S, Chatsiricharoenkul S, Khuhapinant A, Atipas S, Kaewkungwal J. Comparative study of dihydroartemisinin and artesunate safety in healthy Thai volunteers. Int J Clin Pharmacol Ther. 2009; 47(9):579-86. [MEDLINE] PMID: 19761717.
  1. Dway NS, Soonthornworasiri N, Jandee K, Lawpoolsri S, Pan-Ngum W, Sinthuvanich D, et al. Effects of edutainment on knowledge and perceptions of Lisu mothers about the immunisation of their children. Health Education Journal. 2015 January 23, 2015. [MEDLINE] doi: 10.1177/0017896915569086.
  2. Jandee K, Kaewkungwal J, Khamsiriwatchara A, Lawpoolsri S, Wongwit W, Wansatid P. Effectiveness of Using Mobile Phone Image Capture for Collecting Secondary Data: A Case Study on Immunization History Data Among Children in Remote Areas of Thailand. JMIR Mhealth Uhealth. 2015;  3(3):e75. [MEDLINE] PMCID: PMID: 26194880. doi: 10.2196/mhealth.4183.
  3. Kaewkungwal J, Apidechkul T, Jandee K, Khamsiriwatchara A, Lawpoolsri S, Sawang S, et al. Application of mobile technology for improving expanded program on immunization among highland minority and stateless populations in northern Thailand border. JMIR Mhealth Uhealth. 2015; 3(1):e4. [MEDLINE] PMCID: 4319147. PMID: 25589367. doi: 10.2196/mhealth.3704.
  1. Chiarakul S, Eunumjitkul K, Vorapimol AR, Kaewkungwal J, Chimparlee N, Poovorawan Y. Response of health care workers with isolated antibody to hepatitis B core antigen to hepatitis B vaccine. Southeast Asian J Trop Med Public Health. 2011; 42(4):831-8. [MEDLINE] PMID: 22299465.
  2. Chiarakul S, Eunumjitkul K, Vuttiopas S, Vorapimol AR, Kaewkungwal J, Poovorawan Y. Seroprevalence and risk factors of hepatitis B virus infection among health care workers at the Institute of Neurology. J Med Assoc Thai. 2007; 90(8):1536-45. [MEDLINE] PMID: 17926982.
  1. Verachai V, Rukngan W, Chawanakrasaesin K, Nilaban S, Suwanmajo S, Thanateerabunjong R, et al. Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine. Psychopharmacology. 2014; 231(16):3099-108. [MEDLINE] PMID: 24535654. doi: 10.1007/s00213-014-3485-6.
  1. Sangpring P, Vongsirinavarat M, Hiengkaew V, Kaewkungwal J. Development of a Geriatric Fear of Falling Questionnaire for Assessing the Fear of Falling of Thai Elders. Journal of Physical Therapy Science. 2012; 24(4):359. [MEDLINE] PMID: 78152771.
  1. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kim J, Kaewkungwal J, Gurunathan S, et al. Phase III Trial of HIV Prime-Boost Vaccine Combination in Thailand: Follow up Phase (Abstract).  AIDS VACCINE October, 13-16; Cape Town, South Africa 2008. p. 176.
  2. Pitisuttithum P, Rerks-Ngarm S, Kaewkungwal J, Nitayaphan S, Benenson M, Paris R, et al. The Follow-up Phase of the Phase III Community Trial: Current Activities (Oral Presentation).  AIDS VACCINE; October, 13-16; Cape Town, South Africa 2008. p. 64.
  3. Kaewkungwal J, Pitisuttithum P, Nitayapan S, Khamboonruang C, Thongchareon P, Kunasol P, et al. Monitoring selection bias in phase III vaccine trail of ALVAC vaccine priming, AIDSVAX vaccine boosting in Thailand (Abstract). AIDS 2008 Abstract Book. 2008; 2:118-9.
  4. Rerks-Ngarm S, Chunsuttiwat S, Pitisuttithum P, Nittayaphan S, Kaewkungwal J, Kim JH, et al. Thai Prime-boost HIV vaccine phase III trial: update 2007 (Abstract).  AIDS VACCINE; August, 20-23; Seattle, USA 2007. p. 102.
  5. Pitisuttithum P, Rerks-Ngarm S, Kaewkungwal J, Nitayaphan S, Khamboonruang C, Kunasol P, et al. Women participation in the phase III efficacy trial of ALVAC HIV-1 vaccine priming, AIDSVAX vaccine boosting in Thailand (Abstract).  AIDS VACCINE August, 20-23; Seattle, USA 2007. p. 92.
  6. Rerks-Ngam S, Pitisuttithum P, Kitayaporn D, Khamboonruang C, Nitayapan S, Arthur EB, et al. Chapter 7 Conducting Phase III Trials of Candidate HIV Vaccines: The Rayong-Chonburi Community Phase III HIV Vaccine Trial. In: Pitisuttithum P FD, Esparza J, Thongcharoen P,, editor. HIV Vaccine Research and Development in Thailand. Bangkok: Amarin Printing and Publishing Public Company;  2006. p. 293-305. [Click here]
  7. Pitisuttithum P, Suntharasamai P, Van Griensven S, Vanichsen I, Sangkum U, Hirunras K, et al. Incarceration among injecting drug users (IDUs) participating in the AIDSVAX B/E vaccine efficacy trial in Bangkok Thailand (Abstract).  XIV International AIDS Conference; Barcelona 2002.
  8. Pitisuttithum P, Nitayaphan S, Phonrat B, Heyward W, Gurunathan S, Kim J, et al. Safety of Live Recombinant ALVAC – HIV (vCP1521) Priming with AIDSVAX TM B/E Boosting in Thai HIV – 1 negative Participants: Preliminary Results (Abstract).  6th International Congress on AIDS in Asia and the Pacific; October, 5 – 10 Melbourne , Australia 2001.
  9. Pitisuttithum P, Choopanya K, Phonrat B, Vanichseni S, Sangkum U, Heyward W, et al. The Conduct of Good Clinical Practices (GCP) in the First HIV-1 Vaccine Efficacy Trial in a Developing Country – Bangkok, Thailand (Abstract).  6th International Congress on AIDS in Asia and the Pacific; October, 5-10; Melbourne, Australia 2001.
  10. Pitisuttithum P, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai L, Kitayaporn D, et al. Phase I/II Safety and Immunogenicity Trial of Bivalent rgp120 HIV Vaccine (AIDSVAX TM B/E) in Bangkok, Thailand-Initial Report (Abstract).  The Third Annual Conference on Vaccine Research; April, 30 – May, 2; Washington DC, USA 2000. p. 48.
  11. Pitisuttithum P, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai L, Hiranrus K, et al. Initial Report of a Phase I/II Safety and Immunogenicity Trial AIDSVSX TM B/E rgp120 HIV Vaccine – Bangkok, Thailand (Abstract).  XII International AIDS Conference; July, 9 – 14; Durban,South Africa 2000.
  12. Pitisuttithum P, Bangkok Vaccine Evaluation Group. Social harm monitoring among injecting drug users (IDUs) in a phase III HIV vaccine trial in Bangkok, Thailand-preliminary results (Abstract).  XII International AIDS Conference; July, 9 – 14; Durban, South Africa 2000. p. 443.
  1. Kaewkungwal J, Apidechkul T, Jandee K, Khamsiriwatchara A, Lawpoolsri S, Sawang S, et al. Application of mobile technology for improving expanded program on immunization among highland minority and stateless populations in northern Thailand border. JMIR Mhealth Uhealth. 2015; 3(1):e4. [MEDLINE] PMCID: 4319147. PMID: 25589367. doi: 10.2196/mhealth.3704.
  2. Jandee K, Kaewkungwal J, Khamsiriwatchara A, Lawpoolsri S, Wongwit W, Wansatid P. Effectiveness of Using Mobile Phone Image Capture for Collecting Secondary Data: A Case Study on Immunization History Data Among Children in Remote Areas of Thailand. JMIR Mhealth Uhealth. 2015;  3(3):e75. [MEDLINE] PMID: 26194880. doi: 10.2196/mhealth.4183.
  3. Dway NS, Soonthornworasiri N, Jandee K, Lawpoolsri S, Pan-Ngum W, Sinthuvanich D, et al. Effects of edutainment on knowledge and perceptions of Lisu mothers about the immunisation of their children. Health Education Journal. January 23, 2015. [MEDLINE] doi: 10.1177/0017896915569086.
  4. Monyarit S, Pan-ngum W, Lawpoolsri S, Yimsamran S, Pongnumkul S, Kaewkungwal J, et al. Advantages of using voiced questionnaire and image capture application for data collection from a minority group in rural areas along the Thailand-Myanmar border. Inform Prim Care. 2014; 21(4):179-88. [MEDLINE] PMID: 25479348. doi: 10.14236/jhi.v21i4.84.
  5. Lawpoolsri S, Khamsiriwatchara A, Liulark W, Taweeseneepitch K, Sangvichean A, Thongprarong W, et al. Real-time monitoring of school absenteeism to enhance disease surveillance: a pilot study of a mobile electronic reporting system. JMIR Mhealth Uhealth. 2014; 2(2):e22. [MEDLINE] PMCID: 4114464. PMID: 25099501. DOI: 10.2196/mhealth.3114.
  6. Jandee K, Lawpoolsri S, Taechaboonsermsak P, Khamsiriwatchara A, Wansatid P, Kaewkungwal J. Customized-Language Voice Survey on Mobile Devices for Text and Image Data Collection Among Ethnic Groups in Thailand: A Proof-of-Concept Study. JMIR Mhealth Uhealth. 2014; 2(1):e7. [MEDLINE] PMCID: 4114448. PMID: 25098776. doi: 10.2196/mhealth.3058.
  7. Meankaew P, Kaewkungwal J, Khamsiriwatchara A, Khunthong P, Singhasivanon P, Satimai W. Application of mobile-technology for disease and treatment monitoring of malaria in the “Better Border Healthcare Programme”. Malar J. 2010; 9:237. [MEDLINE] PMCID: 2936405. PMID: 20723223. doi: 10.1186/1475-2875-9-237.
  8. Kaewkungwal J, Singhasivanon P, Khamsiriwatchara A, Sawang S, Meankaew P, Wechsart A. Application of smart phone in “Better Border Healthcare Program”: a module for mother and child care. BMC Med Inform Decis Mak. 2010; 10:69. [MEDLINE] PMCID: 2989931. PMID: 21047412. doi: 10.1186/1472-6947-10-69.
  1. จรณิต แก้วกังวาล, จิตติมา ฐิตวัฒน์, ดวงใจ สหัสสานนท์, เบ็ญจลักษณ์ ผลรัตน์, ประตาป สิงหศิวานนท์, ประวรรณ สุนทรสมัย, et al. ตำราการวิจัยทางคลินิก (Textbook of Clinical Research) – In Thai. พรรณี ปิติสุทธิธรรม, ชยันต์ พิเชียรสุนทร, editors. กรุงเทพมหานคร คณะเวชศาสตร์เขตร้อน มหาวิทยาลัยมหิดล; 2011. [Click here]
  2. Kaewkungwal J. Data Quality Assessment (In Thai). Data Management & Biostatistics Journal. 2006; 1(2): Available from: http://dmbj.ejnal.com/e-journal/showdetail/?show_detail=T&art_id=1213.
  1. Aunhachoke K, Bussaratid V, Chirachanakul P, Chua-Intra B, Dhitavat J, Jaisathaporn K, et al. Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand. Int J Dermatol. 2011; 50(4):428-35. [MEDLINE] PMID: 21413953. doi: 10.1111/j.1365-4632.2010.04715.x.
  1. Khortwong P, Kaewkungwal J. Thai health education program for improving TB migrant’s compliance. J Med Assoc Thai. 2013; 96(3):365-73. [MEDLINE] PMID: 23539943.

“We” turn data into actionable wisdom

Contact Us